Keep Antibiotics Working (KAW) is on the Food and Drug Administration’s (FDA) case again about the growth promotion marketing loophole for antibiotics. Last May, KAW alerted FDA to their concerns that drug manufacturer Novartis was
Continue Reading Antibiotics Coalition Wants Drug Companies to Stop Growth Promotion Marketing
Novartis
Antibiotic Reduction Advocates Target Growth Promotion Marketing Loophole
By Lydia Zuraw on
Last week, the Keep Antibiotics Working (KAW) coalition sent a letter to the U.S. Food and Drug Administration urging the agency to police efforts by drug companies to sidestep Guidance #213 on antibiotics in animal…
Continue Reading Antibiotic Reduction Advocates Target Growth Promotion Marketing Loophole